As of Sep 27
| -0.24 / -1.40%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 17.25, with a high estimate of 19.00 and a low estimate of 16.00. The median estimate represents a +1.89% increase from the last price of 16.93.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.